When you're looking at a new investment for the first time, the best place to start is the company's last quarterly report. Take, for example, health-care stalwart and reliable dividend stock Johnson & Johnson (NYSE:JNJ). The company reported strong results and raised its guidance for the year; but what were the major growth drivers, and how does its valuation stack up against competitors like Abbott Labs (NYSE:ABT)? In the following video, a segment from The Motley Fool's health-care show Market Checkup, analysts David Williamson and Max Macaluso examine the highs and lows of the company's second quarter.

David Williamson has no position in any stocks mentioned. Max Macaluso, Ph.D. has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.